Evidence map›Paper›PMID 29987421›Full record

Trial reportEuropean radiology2019

Follow-up infarct volume as a mediator of endovascular treatment effect on functional outcome in ischaemic stroke.

K C J Compagne, A M M Boers, H A Marquering, O A Berkhemer, A J Yoo, L F M Beenen, R J van Oostenbrugge, W H van Zwam, Y B W E M Roos, C B Majoie and 5 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Observational
  4. Article
  5. Infarct density defined by ADC threshold is associated with long-term functional outcome after endovascular thrombectomy.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in neurology · 2020
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

K C J CompagneDepartment of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, PO Box 2040 3000, CA, Rotterdam, The Netherlands. c.compagne@erasmusmc.nl.ORCID http://orcid.org/0000-0003-0608-835X
A M M BoersDepartment of Radiology and Nuclear Medicine, Academic Medical Center (AMC), Amsterdam, The Netherlands.
H A MarqueringDepartment of Radiology and Nuclear Medicine, Academic Medical Center (AMC), Amsterdam, The Netherlands.
O A BerkhemerDepartment of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, PO Box 2040 3000, CA, Rotterdam, The Netherlands.
A J YooDivision of Neurointervention, Texas Stroke Institute, Dallas-Fort Worth, TX, USA.
L F M BeenenDepartment of Radiology and Nuclear Medicine, Academic Medical Center (AMC), Amsterdam, The Netherlands.
R J van OostenbruggeDepartment of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands.
W H van ZwamCardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
Y B W E M RoosNeurology, Academic Medical Center (AMC), Amsterdam, The Netherlands.
C B MajoieDepartment of Radiology and Nuclear Medicine, Academic Medical Center (AMC), Amsterdam, The Netherlands.
A C G M van EsDepartment of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, PO Box 2040 3000, CA, Rotterdam, The Netherlands.
A van der LugtDepartment of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, PO Box 2040 3000, CA, Rotterdam, The Netherlands.
D W J DippelDepartment of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
H LingsmaDepartment of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
MR CLEAN Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe putative mechanism for the favourable effect of endovascular treatment (EVT) on functional outcome after acute ischaemic stroke is preventing follow-up infarct volume (FIV) progression. We aimed to assess to what extent difference in FIV explains the effect of EVT on functional outcome in a randomised trial of EVT versus no EVT (MR CLEAN).

methodsFIV was assessed on non-contrast CT scan 5-7 days after stroke. Functional outcome was the score on the modified Rankin Scale at 3 months. We tested the causal pathway from intervention, via FIV to functional outcome with a mediation model, using linear and ordinal regression, adjusted for relevant baseline covariates, including stroke severity. Explained effect was assessed by taking the ratio of the log odds ratios of treatment with and without adjustment for FIV.

resultsOf the 500 patients included in MR CLEAN, 60 died and four patients underwent hemicraniectomy before FIV was assessed, leaving 436 patients for analysis. Patients in the intervention group had better functional outcomes (adjusted common odds ratio (acOR) 2.30 (95% CI 1.62-3.26) than controls and smaller FIV (median 53 vs. 81 ml) (difference 28 ml; 95% CI 13-41). Smaller FIV was associated with better outcome (acOR per 10 ml 0.60, 95% CI 0.52-0.68). After adjustment for FIV the effect of intervention on functional outcome decreased but remained substantial (acOR 2.05, 95% CI 1.44-2.91). This implies that preventing FIV progression explains 14% (95% CI 0-34) of the beneficial effect of EVT on outcome.

conclusionThe effect of EVT on FIV explains only part of the treatment effect on functional outcome. KEY POINTS: • Endovascular treatment in acute ischaemic stroke patients prevents progression of follow-up infarct volume on non-contrast CT at 5-7 days. • Follow-up infarct volume was related to functional outcome, but only explained a modest part of the effect of intervention on functional outcome. • A large proportion of treatment effect on functional outcome remains unexplained, suggesting FIV alone cannot be used as an early surrogate imaging marker of functional outcome.

Indexed as

AgedBrainBrain IschemiaEndovascular ProceduresFemaleFollow-Up StudiesHumansMaleMiddle AgedSeverity of Illness IndexThrombectomyTomography, X-Ray ComputedTreatment OutcomeBiomarkersCausalityOutcomeStrokeThrombectomy

Identifiers

PMID29987421
PMCPMC6302877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.